DAEWOONG PHARMACEUTICAL CO., LTD. logo

DAEWOONG PHARMACEUTICAL CO., LTD.

12 Marks
Corp.
First Filed:Oct 8, 2007Latest Filed:Dec 6, 2023Address:35-14, Jeyakgongdan 4-gil, Gyeonggi-do, 18623, KR

Portfolio Overview

Registered
7(58%)
Dead
5(42%)

Top Classes

Class 5
Pharmaceuticals
11(92%)
Class 10
Medical Apparatus
1(8%)

TTAB Proceedings

Total Proceedings
2
As Plaintiff
0(0%)
As Defendant
2(100%)

Top Firms

Leydig, Voit & Mayer, Ltd.(Jun 2015)
3
IPLA, LLP(May 2021)
3
DUANE MORRIS LLP(Dec 2023)
3
Faegre Drinker Biddle & Reat...(Jan 2022)
2
Dennemeyer & Associates, LLC(Oct 2007)
1

Trademark Portfolio

12 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
ENAVOPET
ENAVOPET
Trademark
Word
REGISTERED
Owner:
Serial:79387806
Filed:Dec 6, 2023
Classes:5
Registration:7741505
Registered:Apr 1, 2025
Goods & Services
Medicines for veterinary purposes, namely for treatment of metabolic diseases; animal feed additives for use as nutritional supplements; protein supplements for animals; preparations of trace elements for animal use, namely, vitamin and mineral supplements for animals; veterinary vaccines; vitamins for animals; insecticidal animal shampoos; feeding stimulants for animals; dietary supplements for animals; veterinary preparations for treatment of metabolic diseases; medicated veterinary preparations for treating skin disorders; antibiotic food supplements for animals; anaesthetics; animal feed supplements for veterinary purposes; biological preparations for veterinary purposes, namely, biological reagents for veterinary purposes; biological preparations for veterinary purposes, namely, biological tissue cultures for veterinary purposes; pharmaceutical preparations for the treatment of worms in pets; diapers for pets; medicated animal feed; medicated supplements for foodstuffs for animals; pharmaceuticals for preventing diabetes for veterinary purposes; pharmaceuticals for preventing metabolic diseases for veterinary purposes; pharmaceuticals for treating metabolic diseases for veterinary purposes
ENVLOPET
ENVLOPET
Trademark
Word
REGISTERED
Owner:
Serial:79387804
Filed:Dec 6, 2023
Classes:5
Registration:7741504
Registered:Apr 1, 2025
Goods & Services
Medicines for veterinary purposes, namely, for treatment of metabolic diseases; animal feed additives for use as nutritional supplements; protein supplements for animals; preparations of trace elements for animal use, namely, vitamin and mineral supplements for animals; veterinary vaccines; vitamins for animals; insecticidal animal shampoos; feeding stimulants for animals; dietary supplements for animals; veterinary preparations for treatment of metabolic diseases; pharmaceuticals for treating diabetes for veterinary purposes; medicated veterinary preparations for treating skin disorders; antibiotic food supplements for animals; anaesthetics; animal feed supplements for veterinary purposes; biological preparations for veterinary purposes, namely, biological reagents for veterinary purposes; biological preparations for veterinary purposes, namely, biological tissue cultures for veterinary purposes; pharmaceutical preparations for the treatment of worms in pets; diapers for pets; medicated animal feed; medicated supplements for foodstuffs for animals; pharmaceuticals for preventing diabetes for veterinary purposes; pharmaceuticals for preventing metabolic diseases for veterinary purposes; pharmaceuticals for treating metabolic diseases for veterinary purposes
SUNAVO
SUNAVO
Trademark
Word
REGISTERED
Owner:
Serial:79387805
Filed:Dec 6, 2023
Classes:5
Registration:7805586
Registered:May 27, 2025
Goods & Services
Medicines for veterinary purposes, namely for treatment of metabolic diseases; animal feed additives for use as nutritional supplements; protein supplements for animals; preparations of trace elements for animal use, namely, vitamin and mineral supplements for animals; veterinary vaccines; vitamins for animals; insecticidal animal shampoos; feeding stimulants for animals; dietary supplements for animals; veterinary preparations for treatment of metabolic diseases; pharmaceuticals for treating diabetes for veterinary purposes; medicated veterinary preparations for treating skin disorders; antibiotic food supplements for animals; anaesthetics; animal feed supplements for veterinary purposes; biological preparations for veterinary purposes, namely, biological reagents for veterinary purposes; biological preparations for veterinary purposes, namely, biological tissue cultures for veterinary purposes; pharmaceutical preparations for the treatment of worms in pets; diapers for pets; medicated animal feed; medicated supplements for foodstuffs for animals; pharmaceuticals for preventing diabetes for veterinary purposes; pharmaceuticals for preventing metabolic diseases for veterinary purposes; pharmaceuticals for treating metabolic diseases for veterinary purposes
FEXUCLUE
FEXUCLUE
Trademark
Combined
REGISTERED
Owner:
Serial:79335933
Filed:Jan 19, 2022
Classes:5
Registration:7123404
Registered:Aug 1, 2023
Goods & Services
Pharmaceutical agents affecting digestive organs; medicines for treating intestinal disorders; Pharmaceutical preparations in the nature of proton-pump inhibitors for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; medicines for the treatment of gastrointestinal diseases; medicines for human purposes for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; ethical medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection
FEXUCLUE
FEXUCLUE
Trademark
Word
REGISTERED
Owner:
Serial:79314001
Filed:May 13, 2021
Classes:5
Registration:6908928
Registered:Nov 29, 2022
Goods & Services
Pharmaceutical agents affecting digestive organs for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; Medicines for treating intestinal disorders; Pharmaceutical preparations in the nature of proton-pump inhibitors for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; Medicines for the treatment of gastrointestinal diseases; Medicines for human purposes for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; Pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; Ethical medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection
CLODEW
CLODEW
Trademark
Word
REGISTERED
Owner:
Serial:90696094
Filed:May 7, 2021
Classes:5
Registration:6717900
Registered:May 3, 2022
Goods & Services
Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction and pelvic pain; Pharmaceutical preparations, namely, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; Medicines for the treatment of gastrointestinal diseases; chemical preparations for pharmaceutical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; chemico-pharmaceutical preparations for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; drugs for medical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; Medicines for human purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; pharmaceutical preparations for activating cellular function; Adjuvants for medical purposes; pharmaceutical preparations for central nerve treatment, namely, for the treatment of sequelae caused by damage to the central nerve in the brain; dermatological pharmaceutical products, namely, injectable botulinum toxin for refining wrinkles; pharmaceutical preparations for treating skin disorders; antibiotic preparations; pharmaceutical preparations for chemical disorder treatment, namely, for treatment of chemical imbalance in the brain
NABOTA
NABOTA
Trademark
Word
REGISTERED
Owner:
Serial:88938201
Filed:May 28, 2020
Classes:5
Registration:6383994
Registered:Jun 15, 2021
Goods & Services
Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction and pelvic pain; Pharmaceutical preparations, namely, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; Medicines for the treatment of gastrointestinal diseases; chemical preparations for pharmaceutical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; chemico-pharmaceutical preparations for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain. drugs for medical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; Medicines for human purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; pharmaceutical preparations for activating cellular function; Adjuvants for medical purposes; pharmaceutical preparations for central nerve treatment, namely, for the treatment of sequelae caused by damage to the central nerve in the brain; dermatological pharmaceutical products, namely, injectable botulinum toxin for refining wrinkles; pharmaceutical preparations for treating skin disorders; antibiotic preparations; pharmaceutical preparations for chemical disorder treatment, namely, for treatment of chemical imbalance in the brain
EASYEF
EASYEF
Trademark
Stylized
CANCELLED
Owner:
Serial:86663931
Filed:Jun 16, 2015
Classes:5
Registration:5015765
Registered:Aug 9, 2016
CLODEW
CLODEW
Trademark
Word
CANCELLED
Owner:
Serial:86057907
Filed:Sep 6, 2013
Classes:5
Registration:4623497
Registered:Oct 21, 2014
URSA
URSA
Trademark
Word
ABANDONED
Owner:
Serial:85906769
Filed:Apr 17, 2013
Classes:5
NABOTA
NABOTA
Trademark
Word
CANCELLED
Owner:
Serial:85902409
Filed:Apr 12, 2013
Classes:5
Registration:4535957
Registered:May 27, 2014
COOLSKIN
COOLSKIN
Trademark
Word
CANCELLED
Owner:
Serial:77298342
Filed:Oct 8, 2007
Classes:10
Registration:3597206
Registered:Mar 31, 2009

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.